Top NYC, NY Big Data Companies With Best Stability & Growth (310)

Strong Revenue Growth: Revenue has increased for six consecutive quarters, including a 10% year-over-year rise to $148 million in fiscal Q3 2026. Gains are attributed to higher-priced premium lead products and growth in seller, new homes, and rentals.

Strong Market Position & Advantage: The platform is described as the No. 2 U.S. real estate portal with roughly 261 million monthly visits and about 31% visit share in Q3 FY2026. Engagement is characterized as leading peers with the highest visits-per-unique-user among major portals.

Diversified Revenue Streams: Growth is supported by expansion beyond traditional lead resale into seller services, new homes, rentals, and paid exposure offerings. The introduction of products like RealPro Select is cited as bolstering monetization across categories.

Strong Revenue Growth: Revenue is reported at $46.1 billion for 2025, up 6.9% year over year, placing the company at No. 100 on the 2026 Fortune 500. These figures indicate expanding scale on a consolidated basis.

Investor Backing & Capital Strength: Total adjusted capital rose to $34.4 billion at year‑end 2025 with all major ratings affirmed, and AM Best assigned “aa-” to a new $1.0 billion surplus‑note issuance. A record estimated $2.9 billion policyowner dividend for 2026 reinforces retained strength for a mutual insurer.

Diversified Revenue Streams: The business spans whole life, annuities, institutional solutions, and asset management via Barings, with additional contributions from Rothesay. Disclosures describe broad‑based sales and earnings across these engines, helping smooth cyclicality.

Product Line Growth: Since 2025, the company has expanded beyond core data observability into AI agent monitoring, shipping Unstructured Data Monitoring (May 28, 2025) and Agent Lineage (June 21, 2026). This broadens the platform’s surface area and indicates ongoing investment in new capabilities.

Strategic Partnerships: Support for Databricks’ Agent Bricks was announced on June 15, 2026, alongside active presence at major ecosystem events like Databricks Data + AI Summit 2026 and Snowflake Summit 2026. These ties underscore alignment with leading enterprise data and AI platforms.

Investor Backing & Capital Strength: A $135M Series D at a $1.6B valuation in May 2022 signals strong investor support. This late‑stage funding provides a capital base to pursue product and go‑to‑market expansion.

Strong Revenue Growth: Net revenue increased in fiscal 2025 and continued to rise in early 2026, with management characterizing the start of the year as solid and reaffirming the full‑year outlook. This points to ongoing top‑line momentum despite a normalizing environment.

Strong Market Position & Advantage: The company reports a clear global leadership position in biscuits and a top‑tier position in chocolate, underpinned by iconic brands across many countries. Such scale and category strength support steady demand and pricing resilience through input‑cost volatility.

Future-Ready Strategy: Management reiterates a long‑term growth algorithm for organic revenue and EPS and has sharpened focus on core snacks through portfolio actions like the gum divestiture. This signals a durable strategic frame aimed at resilient, sustainable expansion beyond near‑term swings.

Strong Hiring & Retention: Headcount is depicted rising from roughly 1,428 in 2023 to about 1,597 by 2026, with additions in engineering and sales/marketing that typically track with revenue expansion.

Product Line Growth: In 2026 the company launched rtb.com, a self‑service performance platform for SMBs, expanding beyond its historically managed‑service DSP model and opening a broader customer segment.

Market Expansion: Corporate profiles indicate operations in 90+ markets with 30+ offices, signaling sustained geographic scale and demand across regions.

Investor Backing & Capital Strength: Recent late-stage financings — a February 2026 Series D followed by a May 2026 Series E at a higher stated valuation — indicate strong capital access and confidence. Disclosures cite prominent investors and a sizable valuation step‑up, providing resources to scale.

Market Expansion: Company communications describe reach to almost 800 employer clients and multi‑million member coverage, signaling a broader commercial footprint across the employer market. New feature releases such as Predictive Outreach and added distribution channels support this expanding reach.

Strategic Partnerships: Collaborations announced in 2026 with Priority Health and Atlantic Health extend distribution to commercial employer groups through plan and health‑system channels. These partnerships reinforce access to steer members toward higher‑performing providers.

Investor Backing & Capital Strength: Capital raised is described as substantial, with a $372M Series D in June 2024 led by a16z and participation from Sanofi, explicitly earmarked to grow the pipeline and AI platform. References to $600M+ in total funding and ongoing hiring point to a reinforced capital base supporting expansion.

Strategic Partnerships: Collaborations with Sanofi and OpenAI are presented as first-in-class efforts to apply AI across drug development, signaling external validation and increased resourcing. A 2025 Sanofi licensing deal worth up to €545M further indicates the capability to progress and transact assets with blue‑chip partners.

Product Line Growth: Pipeline activity is shown to be broadening via in‑licensing (e.g., a CNS‑penetrant TYK2 inhibitor in Dec 2025) and movement into the clinic, including first‑in‑human dosing on June 9, 2026. Together, these moves suggest more programs are entering and advancing through clinical stages.

Strong Revenue Growth: Revenue is rising at a double‑digit pace in the latest quarter on a reported basis, with underlying organic growth continuing in the high single digits. Management raised the full‑year outlook after exceeding Q1 targets across revenue, adjusted EBITDA, and adjusted EPS.

Innovation-Driven Growth: Outperformance is linked to innovation‑led demand in analytics and AI, with launches such as TruIQ and enhanced fraud models supporting momentum, particularly in U.S. Financial Services. Management characterizes this phase as innovation‑led and scalable, underpinning sustained organic expansion.

Market Expansion: A controlling stake in Trans Union de Mexico was added and is expected to be accretive to current‑year adjusted EPS. Additional portfolio moves in identity and communications expand the company’s presence in adjacent, faster‑growing categories.

Strong Revenue Growth: Public disclosures indicate revenue surpassed $1B in 2023 and remained above that level in 2024–2025, with 2024 noted at roughly $1.1B. These signals point to ongoing top‑line expansion.

Product Line Growth: Recent launches and releases such as IntelliCare and the 2026.1 updates for IRIS, IRIS for Health, and Health Connect highlight an active roadmap. This cadence is presented as expanding the addressable market and creating new upsell paths.

Strong Market Position & Advantage: Industry recognition places the company as a Leader in the 2026 Gartner Magic Quadrant for Enterprise EHRs and the 2025–2026 IDC MarketScape for analytical databases, alongside multiple 2026 Best in KLAS #1 rankings. These placements signal competitive strength and buyer traction in core markets.

Strong Revenue Growth: Revenue is reported at about $1.27B for 2025 (~80–83% YoY), with Q4 2025 at $367.2M (+83% YoY) and Q1 2026 at $348.1M (+36% YoY); full‑year 2026 is guided to $1.59–$1.60B (~25% growth). Segment data show Diagnostics up 34.7% and Data & Applications up 40.5% YoY in Q1 2026.

Strategic Partnerships: Record total contract value exceeding $1.1B and multi‑year collaborations with AstraZeneca, Merck, Gilead, and Bristol Myers Squibb are highlighted. These arrangements support growth in data/software lines and add forward revenue visibility.

Product Line Growth: MRD testing reached ~6,500 in Q1 2026 (up ~500% YoY), and acquisitions of Ambry Genetics, Paige.AI, and Deep 6 AI broaden testing and AI capabilities. Management points to horizontal integration and cross‑selling (e.g., with Ambry) as contributors to expected growth.

Investor Backing & Capital Strength: A $70M Series C announced on May 28, 2025 with participation from firms like Sequoia, a16z, Redpoint, and Snowflake Ventures suggests strong investor conviction and runway. Private‑market trackers indicating a roughly $620M post‑money estimate reinforce available capital for scaling.

Innovation-Driven Growth: Public changelogs and site updates highlight steady 2025–2026 releases across AI agents, embedded analytics, and “Magic” capabilities. This cadence points to continued R&D investment and expanding platform breadth.

Strategic Partnerships: Visibility with major ecosystems—such as a Snowflake Partner Award mention and participation at Databricks Data + AI Summit—indicates traction with key data platforms. These signals act as proxies for go‑to‑market momentum within those channels.

Profitability: Margins and adjusted EBITDA are improving year over year, with a recent quarter achieving GAAP profitability alongside higher gross profit. Management also indicates continued margin expansion into 2026.

Product Line Growth: Multi-product adoption is rising, and newer offerings such as ACH fraud intelligence, identity data tools, and ARIA are contributing a larger share of the business. This broadened mix complements the core Chargeback Guarantee product.

Market Expansion: New wins across regions and verticals, together with partnerships (for example, Radial, Outpayce from Amadeus, and SB Payment Service), are extending reach and pipeline. Momentum outside the U.S. and in categories like Money Transfer & Payments is specifically highlighted.

Strong Market Position & Advantage: Market leadership is repeatedly highlighted across major analyst assessments and market-share studies, with Celonis consistently positioned as a top vendor as the category expands. This stature indicates the company is capturing outsized benefit from overall market growth and reinforcing competitive advantage.

Innovation-Driven Growth: Product momentum is evident through launches like the Context Model and the agreement to acquire Ikigai Labs to deepen decision‑intelligence and AI capabilities. Frequent platform updates and portfolio expansion signal ongoing investment to broaden use cases and drive expansion.

Investor Backing & Capital Strength: Celonis secured substantial additional liquidity in 2022 via equity financing and an expandable revolving credit facility to support scaling. This capital base is described as fueling product development, M&A, and go‑to‑market initiatives.

Strong Revenue Growth: Revenue rose roughly 30–34% year over year across Q1–Q3 FY2026 while GMV increased 35–36%, indicating sustained top-line momentum and expanding transaction scale.

Profitability: GAAP profitability emerged with $80.7M net income in Q1 FY2026 and $88M GAAP operating income with $103M net income in Q3 FY2026, showing a clear shift from prior losses.

Product Line Growth: The Affirm Card is scaling rapidly, with 4.4M active cardholders (+130% YoY) and card GMV up about 146–159% YoY, lifting direct-to-consumer GMV by roughly 48–52%.

Strong Revenue Growth: Revenue is rising year over year in 2025 and Q1 2026, and full‑year 2026 guidance was raised above prior actuals after results exceeded the high end of guidance. Momentum is described as supported by the Yahoo ramp and newer performance offerings such as Realize.

Profitability: Net income turned positive for 2025 and Q1 2026 alongside solid adjusted EBITDA and growing free cash flow. These results indicate improving earnings quality while the business scales.

Strategic Partnerships: A 30‑year exclusive native‑ads agreement with Yahoo has been ramping and is framed as a major, long‑term revenue opportunity and driver of ex‑TAC growth. Additional distribution and product initiatives further extend reach across premium publishers and devices.

Strong Revenue Growth: ARR is described as more than tripling in 2025, with recurring subscription and services revenue up over 220% year over year. Announcements in early 2026 attribute this surge to expanding adoption among private‑equity sponsors and portfolio companies.

Product Line Growth: The company has introduced and expanded offerings such as an AI‑powered Pricing Suite and healthcare‑focused Astradis capabilities, alongside fresh product and solution pages in 2026. This cadence signals continued investment in its decision‑intelligence platform.

Market Expansion: The footprint has widened with new or expanded offices in Bengaluru, Dallas, New York, and Toronto, plus a larger Chicago space, while sponsor relationships reportedly doubled to extend reach across hundreds of billions in AUM. Public materials emphasize a growing base among PE sponsors and portfolio companies.

Strong Revenue Growth: Full-year 2025 revenue increased mid- to high‑single digits (about 7–8% with roughly 8% organic), and Q1 2026 reported revenue rose 10.8% with 7.6% organic growth. Disclosures point to contributions from Morningstar Credit, the Morningstar Direct Platform, PitchBook, and Morningstar Retirement.

Profitability: Operating income expanded sharply in Q1 2026 (+36.6%) alongside a 50% increase in diluted EPS, following higher operating and adjusted operating income in 2025. These results indicate operating leverage continuing into 2026.

Cost & Operational Efficiency: Headcount was essentially flat from 2023 to 2026 while revenue and margins improved, implying productivity and pricing/mix as key growth drivers. Targeted reorganizations cited in filings supported margin expansion and focus.

Investor Backing & Capital Strength: Investor backing is underscored by a $100 million minority investment from Blackstone Growth in January 2026, described as a Series C with a notable valuation step-up. Feedback suggests this top-tier funding signals confidence and provides resources to scale.

Strong Hiring & Retention: Hiring momentum is evident with headcount rising from about 308 in 2024 to roughly 399 by December 2025 and ongoing recruiting into 2026. Feedback suggests multiple job postings and “growing quickly” language point to continued team expansion.

Strong Revenue Growth: Revenue trajectory is portrayed as rapid, with company materials claiming 10x growth over four years (not independently audited). Feedback suggests this aligns with the scaling narrative tied to recent funding and hiring.

Strong Revenue Growth: Revenues and subscription recurring metrics have risen sharply across recent quarters and fiscal years, with management raising full‑year guidance following better‑than‑expected results. Growth is supported by expanding large‑customer counts and continued demand for cyber resilience offerings.

Healthy Cash Flow: Free cash flow has turned positive and improved, including a strong margin in the latest quarter, indicating better operating leverage as scale increases. Cash generation has strengthened even while the company continues to invest for growth.

Strong Market Position & Advantage: The company is repeatedly recognized as a category Leader by major analyst firms and reports share gains in its core segment. Leadership messaging around security and AI operations, plus high enterprise adoption, reinforces competitive positioning.

Investor Backing & Capital Strength: The August 2025 agreement for Blackstone to acquire the company at a multibillion‑dollar valuation signals strong sponsor support and financing capacity for continued scaling. Subsequent 2026 references to Enverus as a Blackstone company reinforce available capital during its expansion.

Product Line Growth: New analytics and AI offerings—such as Investor Analytics (April 2025), Enverus AI (late 2025), and the Enverus ONE platform (2026)—indicate continued investment in the product stack and addressable workflows. These launches extend coverage from core upstream into power markets and AI‑enabled execution.

Market Expansion: Acquisitions spanning utility design (Spatial Business Systems), grid interconnection (Pearl Street Technologies), upstream operational exchanges (PDS platforms), and subsurface data (A2D well log library) point to expansion across upstream, power/renewables, and utility engineering workflows. Company materials also highlight a broad global customer footprint across many countries.